Natera co-founder Jonathan Sheena sells 3 and 109 shares

The sales addressed RSU-related tax withholding and remittance obligations under a written instruction associated with a Stock Unit Agreement.

Available on EDGAR 11/04/2026 - 09:35 PM EST Accepted by SEC EDGAR 11/04/2026 - 09:35 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Natera, Inc. director and co-founder Jonathan Sheena reported selling 3 shares of common stock at $388.20 per share and 109 shares at $400.2942 per share on November 2, 2026. The sales were made to satisfy tax withholding and remittance obligations connected with RSU vesting, under a written instruction intended to satisfy Rule 10b5-1(c)'s affirmative-defense conditions. The instruction was contained in a Stock Unit Agreement granted January 31, 2025.

The records separately list 8,250 shares held for beneficiaries of Caraluna 1 Trust and 8,250 shares held for beneficiaries of Caraluna 2 Trust. Sheena disclaims beneficial ownership of those securities.

Insider Trade Summary 10b5-1

Net Seller: 112 shares

Net Sell 2 txns

Insider Sheena Jonathan

Role Director

Sold 112 shs ($45K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	3	$388.20	$1K
Sale	Common Stock F1	109	$400.2942	$44K
Holding	Common Stock F2	--	--	--
Holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 217,574 shares (Direct); Common Stock — 8,250 shares (Indirect, by Caraluna 1 Trust); Common Stock — 8,250 shares (Indirect, By Caraluna 2 Trust)

Footnotes (2)

1. F1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
2. F2. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

Key Figures

Common shares sold: 3 shares at $388.20 per share Common shares sold: 109 shares at $400.2942 per share Caraluna 1 Trust shares: 8,250 shares +1 more

4 metrics

Common shares sold 3 shares at $388.20 per share Sale on November 2, 2026

Common shares sold 109 shares at $400.2942 per share Sale on November 2, 2026

Caraluna 1 Trust shares 8,250 shares Held for the benefit of the trust's beneficiaries

Caraluna 2 Trust shares 8,250 shares Held for the benefit of the trust's beneficiaries

Key Terms

RSUs, Rule 10b5-1(c), Stock Unit Agreement, beneficial ownership

4 terms

RSUs financial

"vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Rule 10b5-1(c) regulatory

"affirmative defense conditions of Rule 10b5-1(c)"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

Stock Unit Agreement technical

"contained in the Reporting Person's Stock Unit Agreement"

beneficial ownership regulatory

"disclaims beneficial ownership over such securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTRA shares did Jonathan Sheena sell, and at what prices?

Jonathan Sheena reported selling 3 NTRA common shares at $388.20 per share and 109 shares at $400.2942 per share on November 2, 2026. The sales were made to satisfy tax withholding and remittance obligations connected with RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheena Jonathan

(Last) (First) (Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN TEXAS 78753

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			CO-FOUNDER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/02/2026		S		3(1)	D	$388.2	217,683	D
Common Stock	11/02/2026		S		109(1)	D	$400.2942	217,574	D
Common Stock								8,250	I	by Caraluna 1 Trust(2)
Common Stock								8,250	I	By Caraluna 2 Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.

2. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

	/s/ Tami Chen, Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)